Global Viscosupplementation Injection 麻豆原创 Growth 2024-2030

Publication ID:

LPI01240794

Publication Date:

January 11, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Viscosupplementation Injection market size was valued at US$ 1115.4 million in 2023. With growing demand in downstream market, the Viscosupplementation Injection is forecast to a readjusted size of US$ 1667.5 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Viscosupplementation Injection market. Viscosupplementation Injection are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Viscosupplementation Injection. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Viscosupplementation Injection market.
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.
Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.
Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%.
North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.
Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.
Key Features:
The report on Viscosupplementation Injection market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Viscosupplementation Injection market. It may include historical data, market segmentation by Type (e.g., Single Injection, Three Injection), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Viscosupplementation Injection market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Viscosupplementation Injection market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Viscosupplementation Injection industry. This include advancements in Viscosupplementation Injection technology, Viscosupplementation Injection new entrants, Viscosupplementation Injection new investment, and other innovations that are shaping the future of Viscosupplementation Injection.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Viscosupplementation Injection market. It includes factors influencing customer ' purchasing decisions, preferences for Viscosupplementation Injection product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Viscosupplementation Injection market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Viscosupplementation Injection market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Viscosupplementation Injection market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Viscosupplementation Injection industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Viscosupplementation Injection market.
麻豆原创 Segmentation:
Viscosupplementation Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Single Injection
Three Injection
Five Injection
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Key Questions Addressed in this Report
What is the 10-year outlook for the global Viscosupplementation Injection market?
What factors are driving Viscosupplementation Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Viscosupplementation Injection market opportunities vary by end market size?
How does Viscosupplementation Injection break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Viscosupplementation Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Viscosupplementation Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Viscosupplementation Injection by Country/Region, 2019, 2023 & 2030
2.2 Viscosupplementation Injection Segment by Type
2.2.1 Single Injection
2.2.2 Three Injection
2.2.3 Five Injection
2.3 Viscosupplementation Injection Sales by Type
2.3.1 Global Viscosupplementation Injection Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Viscosupplementation Injection Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Viscosupplementation Injection Sale Price by Type (2019-2024)
2.4 Viscosupplementation Injection Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Viscosupplementation Injection Sales by Application
2.5.1 Global Viscosupplementation Injection Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Viscosupplementation Injection Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Viscosupplementation Injection Sale Price by Application (2019-2024)
3 Global Viscosupplementation Injection by Company
3.1 Global Viscosupplementation Injection Breakdown Data by Company
3.1.1 Global Viscosupplementation Injection Annual Sales by Company (2019-2024)
3.1.2 Global Viscosupplementation Injection Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Viscosupplementation Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Viscosupplementation Injection Revenue by Company (2019-2024)
3.2.2 Global Viscosupplementation Injection Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Viscosupplementation Injection Sale Price by Company
3.4 Key Manufacturers Viscosupplementation Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Viscosupplementation Injection Product Location Distribution
3.4.2 Players Viscosupplementation Injection Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Viscosupplementation Injection by Geographic Region
4.1 World Historic Viscosupplementation Injection 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Viscosupplementation Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Viscosupplementation Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Viscosupplementation Injection 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Viscosupplementation Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Viscosupplementation Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Viscosupplementation Injection Sales Growth
4.4 APAC Viscosupplementation Injection Sales Growth
4.5 Europe Viscosupplementation Injection Sales Growth
4.6 Middle East & Africa Viscosupplementation Injection Sales Growth
5 Americas
5.1 Americas Viscosupplementation Injection Sales by Country
5.1.1 Americas Viscosupplementation Injection Sales by Country (2019-2024)
5.1.2 Americas Viscosupplementation Injection Revenue by Country (2019-2024)
5.2 Americas Viscosupplementation Injection Sales by Type
5.3 Americas Viscosupplementation Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viscosupplementation Injection Sales by Region
6.1.1 APAC Viscosupplementation Injection Sales by Region (2019-2024)
6.1.2 APAC Viscosupplementation Injection Revenue by Region (2019-2024)
6.2 APAC Viscosupplementation Injection Sales by Type
6.3 APAC Viscosupplementation Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Viscosupplementation Injection by Country
7.1.1 Europe Viscosupplementation Injection Sales by Country (2019-2024)
7.1.2 Europe Viscosupplementation Injection Revenue by Country (2019-2024)
7.2 Europe Viscosupplementation Injection Sales by Type
7.3 Europe Viscosupplementation Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Viscosupplementation Injection by Country
8.1.1 Middle East & Africa Viscosupplementation Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Viscosupplementation Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Viscosupplementation Injection Sales by Type
8.3 Middle East & Africa Viscosupplementation Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Viscosupplementation Injection
10.3 Manufacturing Process Analysis of Viscosupplementation Injection
10.4 Industry Chain Structure of Viscosupplementation Injection
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Viscosupplementation Injection Distributors
11.3 Viscosupplementation Injection Customer
12 World Forecast Review for Viscosupplementation Injection by Geographic Region
12.1 Global Viscosupplementation Injection 麻豆原创 Size Forecast by Region
12.1.1 Global Viscosupplementation Injection Forecast by Region (2025-2030)
12.1.2 Global Viscosupplementation Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Viscosupplementation Injection Forecast by Type
12.7 Global Viscosupplementation Injection Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Viscosupplementation Injection Product Portfolios and Specifications
13.1.3 Sanofi Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Anika Therapeutics
13.2.1 Anika Therapeutics Company Information
13.2.2 Anika Therapeutics Viscosupplementation Injection Product Portfolios and Specifications
13.2.3 Anika Therapeutics Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Anika Therapeutics Main Business Overview
13.2.5 Anika Therapeutics Latest Developments
13.3 Seikagaku
13.3.1 Seikagaku Company Information
13.3.2 Seikagaku Viscosupplementation Injection Product Portfolios and Specifications
13.3.3 Seikagaku Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Seikagaku Main Business Overview
13.3.5 Seikagaku Latest Developments
13.4 Zimmer Biomet
13.4.1 Zimmer Biomet Company Information
13.4.2 Zimmer Biomet Viscosupplementation Injection Product Portfolios and Specifications
13.4.3 Zimmer Biomet Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Zimmer Biomet Main Business Overview
13.4.5 Zimmer Biomet Latest Developments
13.5 Bioventus
13.5.1 Bioventus Company Information
13.5.2 Bioventus Viscosupplementation Injection Product Portfolios and Specifications
13.5.3 Bioventus Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bioventus Main Business Overview
13.5.5 Bioventus Latest Developments
13.6 Ferring
13.6.1 Ferring Company Information
13.6.2 Ferring Viscosupplementation Injection Product Portfolios and Specifications
13.6.3 Ferring Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Ferring Main Business Overview
13.6.5 Ferring Latest Developments
13.7 LG Chem
13.7.1 LG Chem Company Information
13.7.2 LG Chem Viscosupplementation Injection Product Portfolios and Specifications
13.7.3 LG Chem Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 LG Chem Main Business Overview
13.7.5 LG Chem Latest Developments
13.8 Freda
13.8.1 Freda Company Information
13.8.2 Freda Viscosupplementation Injection Product Portfolios and Specifications
13.8.3 Freda Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Freda Main Business Overview
13.8.5 Freda Latest Developments
13.9 Haohai Biological
13.9.1 Haohai Biological Company Information
13.9.2 Haohai Biological Viscosupplementation Injection Product Portfolios and Specifications
13.9.3 Haohai Biological Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Haohai Biological Main Business Overview
13.9.5 Haohai Biological Latest Developments
13.10 Shanghai Jingfeng
13.10.1 Shanghai Jingfeng Company Information
13.10.2 Shanghai Jingfeng Viscosupplementation Injection Product Portfolios and Specifications
13.10.3 Shanghai Jingfeng Viscosupplementation Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shanghai Jingfeng Main Business Overview
13.10.5 Shanghai Jingfeng Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.